journal article·2008-02-22

A Triantennary Dendritic Galactoside‐Capped Nanohybrid with a ZnS/CdSe Nanoparticle Core as a Hydrophilic, Fluorescent, Multivalent Probe for Metastatic Lung Cancer Cells

Chien‐Tien Chen, Yogesh S. Munot, Santosh B. Salunke, Yi‐Ching Wang, Ruo‐Kai Lin, Chun‐Cheng Lin, Chia‐Chun Chen, Y‐Hasin Liu

Advanced Functional Materials· Volume 18· Issue 4
Publisher page

Abstract

Abstract A new tri‐antennary, galactoside‐capped gallamide dendritic anchor with thiolate focal group is synthesized via click chemistry. The highly hydrophilic dendron was efficiently anchored onto the surface of CdSe/ZnS core/shell nanoparticles in a covalent fashion, as evidenced by 1H NMR spectrum of the resultant nanohybrid with intact core fluorescent property. The water‐soluble nano‐hybrid was found smoothly and selectively uptaken by lung cancer cells enriched with membrane‐bound asialoprotein receptors in 2–3 h, as evidenced by confocal microscopic analysis. Furthermore, cancer cells that are undergoing active mitosis also tend to uptake the nanohybrids efficiently and remain sustainable in serum‐containing medium for several days, which shed light on its application as a photodynamic drug carrier for apoptosis study.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Click Chemistry and Applications · Dendrimers and Hyperbranched Polymers · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (72)

Show source-provided references
1. 10.1126/science.271.5251.93310.1126/science.271.5251.933 ↗
2. 10.1126/science.281.5385.201610.1126/science.281.5385.2016 ↗
3. 10.1021/ar980039x10.1021/ar980039x ↗
4. 10.1021/j100403a00310.1021/j100403a003 ↗
5. 10.1038/370354a010.1038/370354a0 ↗
6. 10.1021/ja015857q10.1021/ja015857q ↗
7. 10.1002/1521-4095(20020618)14:12<882::AID-ADMA882>3.0.CO;2-Y10.1002/1521-4095(20020618)14:12<882::AID-ADMA882>3.0.CO;2-Y ↗
8. 10.1021/ja00072a02510.1021/ja00072a025 ↗
9. 10.1126/science.281.5385.201310.1126/science.281.5385.2013 ↗
10. 10.1021/ja002535y10.1021/ja002535y ↗
11. 10.1351/pac20007201000310.1351/pac200072010003 ↗
12. 10.1016/S1359-0286(02)00081-510.1016/S1359-0286(02)00081-5 ↗
13. 10.1126/science.110427410.1126/science.1104274 ↗
14. 10.1088/0957-4484/16/2/R0110.1088/0957-4484/16/2/R01 ↗
15. 10.1021/ja991662v10.1021/ja991662v ↗
16. 10.1021/ja016711u10.1021/ja016711u ↗
17. 10.1016/j.copbio.2004.11.00310.1016/j.copbio.2004.11.003 ↗
18. 10.1021/ar00056a00110.1021/ar00056a001 ↗
19. 10.1021/cr940283b10.1021/cr940283b ↗
20. 10.1084/jem.184.3.104510.1084/jem.184.3.1045 ↗
21. 10.1093/glycob/3.2.9710.1093/glycob/3.2.97 ↗
22. 10.1021/cr990297n10.1021/cr990297n ↗
23. 10.1351/pac19916304047310.1351/pac199163040473 ↗
24. 10.1021/cr000418f10.1021/cr000418f ↗
25. 10.1016/S0021-9258(18)33240-X10.1016/S0021-9258(18)33240-X ↗
26. 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-310.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3 ↗
27. 10.1002/chem.20020454410.1002/chem.200204544 ↗
28. 10.1002/cbic.20030072610.1002/cbic.200300726 ↗
29. 10.1021/ja020090310.1021/ja0200903 ↗
30. 10.1039/b308995a10.1039/b308995a ↗
31. 10.1021/cr940413g10.1021/cr940413g ↗
32. 10.1021/ar020083j10.1021/ar020083j ↗
33. 10.1021/nl034086g10.1021/nl034086g ↗
34. 10.1021/ja048792a10.1021/ja048792a ↗
35. 10.1002/cbic.20040013710.1002/cbic.200400137 ↗
36. 10.1039/b509781a10.1039/b509781a ↗
37. 10.1016/0092-8674(80)90116-610.1016/0092-8674(80)90116-6 ↗
38. 10.1002/9780470122860.ch310.1002/9780470122860.ch3 ↗
39. 10.1021/bm010053o10.1021/bm010053o ↗
40. 10.1021/bi00495a00110.1021/bi00495a001 ↗
41. 10.1021/bi00313a03710.1021/bi00313a037 ↗
42. Feher F. J. · Chem. Commun. · 1998 · 2394
43. Glinsky V. V. · Cancer Res. · 2001 · 61 · 4851
44. 10.1074/jbc.M10986720010.1074/jbc.M109867200 ↗
45. 10.1093/glycob/cwg09110.1093/glycob/cwg091 ↗
46. 10.1023/B:GLYC.0000014072.34840.0410.1023/B:GLYC.0000014072.34840.04 ↗
47. 10.1002/cbic.20060001110.1002/cbic.200600011 ↗
48. Califice S. · Int. J. Oncol. · 2004 · 25 · 98310.3892/ijo.25.4.983 ↗
49. 10.1023/B:GLYC.0000014084.01324.1510.1023/B:GLYC.0000014084.01324.15 ↗
50. 10.1007/s10495-005-0801-y10.1007/s10495-005-0801-y ↗
51. 10.1038/nrc152710.1038/nrc1527 ↗
52. 10.1016/j.tetasy.2004.12.00310.1016/j.tetasy.2004.12.003 ↗
53. 10.1039/b611050a10.1039/b611050a ↗
54. 10.1016/j.bbagen.2005.12.00110.1016/j.bbagen.2005.12.001 ↗
55. 10.1023/B:GLYC.0000044846.80014.cb10.1023/B:GLYC.0000044846.80014.cb ↗
56. 10.1016/j.tetasy.2004.12.00210.1016/j.tetasy.2004.12.002 ↗
57. 10.1002/cbic.20050011210.1002/cbic.200500112 ↗
58. Tri‐antennary glyco‐silicas with peripheralα‐mannoside have been prepared [28b] but their structural identities were not confirmed and their affinity strengths towards ConA was found to be less efficient than that from the original unfunctionalized silica.
59. 10.1002/adsc.20060025410.1002/adsc.200600254 ↗
60. 10.1039/b418806c10.1039/b418806c ↗
61. 10.1021/ja016711u10.1021/ja016711u ↗
62. 10.1002/1521-3773(20020617)41:12<2113::AID-ANIE2113>3.0.CO;2-Q10.1002/1521-3773(20020617)41:12<2113::AID-ANIE2113>3.0.CO;2-Q ↗
63. 10.1039/b512021g10.1039/b512021g ↗
64. See the Supporting Information for details.
65. 10.1021/ol016684c10.1021/ol016684c ↗
66. 10.1021/jo048487810.1021/jo0484878 ↗
67. 10.1021/ol051178z10.1021/ol051178z ↗
68. 10.1021/ol062375g10.1021/ol062375g ↗
69. 10.1021/ja970754m10.1021/ja970754m ↗
70. 10.1021/ja003633m10.1021/ja003633m ↗
71. Confocal microscopic images withZ‐clipping alongxandyaxes were not checked since no additional useful information can be provided in these two cases.
72. 10.1021/jo990955410.1021/jo9909554 ↗